Polyrizon Raises $3.5 Million to Advance Intranasal Protective Therapy Platform
Polyrizon Ltd. raises $3.5 million to advance its intranasal hydrogel platform—boosting research, clinical milestones, and investor confidence in the biotech sector.
3 minutes to read